Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB

NCT03241459 is registered in ClinicalTrials.gov with SurModics, Inc. as lead sponsor.

NCT NCT03241459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03241459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Lead sponsor
SurModics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2017
Completion date
September 17, 2024
Enrollment
446 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

artery disease, peripheral, femoropopliteal artery occlusion, peripheral arterial disease, peripheral vascular disease